Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 5/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 4/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.79 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.67 |
| ▸ | KCNA2 | P16389 | 2/20 | 0.66 |
| ▸ | BACE1 | P56817 | 3/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.60 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | MAOA | P21397 | 2/20 | 0.60 |
| ▸ | PDE4A | P27815 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopimpinellin SCHEMBL29568822 | 1.00 | CYP3A4 (1.00) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 | |
| SCHEMBL4187228 | 0.89 | CYP3A4 (0.80) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 | |
| SCHEMBL20278781 | 0.89 | CYP3A4 (0.80) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 | |
| SCHEMBL434686 | 0.89 | CYP3A4 (0.80) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 | |
| SCHEMBL31542614 | 0.89 | CYP3A4 (0.80) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 | |
| Isopimpinellin SCHEMBL29787210 | 0.89 | CYP3A4 (0.82) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 | |
| Pimpinellin SCHEMBL2255899 | 0.89 | CYP3A4 (1.00) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 | |
| Pimpinellin SCHEMBL29162721 | 0.87 | CYP3A4 (0.97) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 | |
| SCHEMBL6361059 | 0.86 | CYP3A4 (0.75) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 | |
| SCHEMBL6200404 | 0.85 | CYP3A4 (0.74) | CYP3A4KDM4ECYP1A2CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1073 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20250177275-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN INHIBITION OF SKIN AGING | CUTANEON - SKIN & HAIR INNOVATIONS GMBH (DE) | 2025-06-05 | — | — | US | claimed |
| US-20250143995-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN REGULATION OF SKIN PIGMENTATION | CUTANEON - SKIN & HAIR INNOVATIONS GMBH (DE) | 2025-05-08 | — | — | US | claimed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | claimed |
| CN-119587535-A | Composition containing wampee amide and application thereof in preparation of drugs with liver injury treatment effect | 海南医科大学(海南省医学科学院) | 2025-03-11 | — | — | CN | claimed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| US-12209232-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-28 | — | — | US | claimed |
| CN-119086759-A | Quantitative detection method for eight-seed kidney-tonifying capsule component | 石家庄以岭药业股份有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-119086760-A | Method for determining in-vivo metabolites of Bazi kidney-tonifying capsules | 石家庄以岭药业股份有限公司 | 2024-12-06 | — | — | CN | claimed |
| WO-2004022080-A2 | BUGUZHI AGENT AND COMPOSITION AND METHODS OF PREPARING AND ADMINISTERING THE SAME | THE UNIVERSITY OF HONG KONG (CN) | 2004-03-18 | — | — | WO | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-0954304-A2 | METHODS FOR REGULATING NICOTINE METABOLISM | Nicogen Inc. (CA) | 1999-11-10 | — | — | EP | claimed |
| CN-1230112-A | Method of regulating nicotine metabolism | NICOGEN INC (CA) | 1999-09-29 | — | — | CN | claimed |
| WO-1998003171-A2 | USE OF INHIBITORS OF CYP2A6 FOR REGULATING NICOTINE METABOLISM | NICOGEN INC. (CA) | 1998-01-29 | — | — | WO | claimed |
| US-5571082-A | Method of producing therapeutic effect upon an organism to reduce the pathologic lymphocyte population | BASHIKIROV ALEXEI B (RU) | 1996-11-05 | — | — | US | claimed |
| EP-0352198-B1 | 5-methoxypsoralen and other furocoumarins as jet lag suppressants | GOUPIL JEAN JACQUES (FR) | 1994-04-13 | — | — | EP | claimed |
| CN-1080537-A | The goods of protect against osteoporosis and method for making thereof | MEDICINE TECH DEV CENTRE ZHANJ (CN) | 1994-01-12 | — | — | CN | claimed |
| US-4939167-A | Use of 5-methoxypsoralen and other furocoumarins as jet lag suppressants | JEAN JACQUES GOUPIL (FR) | 1990-07-03 | — | — | US | claimed |
| EP-0352198-A2 | 5-methoxypsoralen and other furocoumarins as jet lag suppressants | Goupil, Jean-Jacques (FR) | 1990-01-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | CYP51A1, ERG28, NISCH | CYP3A4 3888/4885KDM4E 1123/4885CYP1A2 1467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.